(-)-2,6-Diamino-4,5,6,7-Tetrahydrobenzothiazole

(-)-2,6-Diamino-4,5,6,7-Tetrahydrobenzothiazole


    • Product Name (-)-2,6-Diamino-4,5,6,7-Tetrahydrobenzothiazole
    • Alias Bat-808
    • Einecs 256-718-6
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    154510

    Chemical Formula C7H13N3S
    Molar Mass 171.26 g/mol
    Appearance Solid (predicted from similar compounds)
    Solubility In Water Limited solubility (due to non - polar benzothiazole ring and polar amino groups, relative to similar compounds)
    Pka Of Amino Groups Basic pKa values (due to amino groups, likely around 9 - 11 for aliphatic amino groups)
    Stability Can be stable under normal conditions but may react with strong oxidizing agents or acids due to amino groups

    As an accredited (-)-2,6-Diamino-4,5,6,7-Tetrahydrobenzothiazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 500g of (-)-2,6 - Diamino - 4,5,6,7 - Tetrahydrobenzothiazole in sealed chemical - grade bags.
    Shipping The chemical (-)-2,6 - Diamino-4,5,6,7 - Tetrahydrobenzothiazole is shipped in containers suitable for chemicals. It's packaged to prevent spills and ensure safety during transit, following strict regulations for hazardous substances.
    Storage (-)-2,6 - Diamino - 4,5,6,7 - Tetrahydrobenzothiazole should be stored in a cool, dry place, away from heat sources and direct sunlight. Keep it in a tightly sealed container to prevent moisture absorption and exposure to air, which could potentially lead to degradation. Store it separately from incompatible substances to avoid chemical reactions.
    Application of (-)-2,6-Diamino-4,5,6,7-Tetrahydrobenzothiazole

    Manufacture of pramipexole dihydrochloride monohydrate under ICH Q7 GMP guidelines encounters a critical yield bottleneck during late-stage diastereomeric salt resolution if a classical racemic route is adopted. Introducing (–)-2,6-diamino-4,5,6,7-tetrahydrobenzothiazole as the starting material of predefined (S)-configuration bypasses the chiral separation of racemic diamine intermediates entirely, shifting the enantiomeric purity determination upstream. The diamine is N-propylated using 1.15 equivalents of propionaldehyde in methanol at 0–5 °C in the presence of sodium cyanoborohydride (1.3 eq) and acetic acid (0.8 eq), followed by hydrochloride salt formation in isopropanol/HCl to deliver crude pramipexole base with a chemical purity exceeding 99.0% by HPLC (USP <621>). Process-scale executions in 3,000 L glass-lined reactors equipped with retreat-curve impellers and jacket cooling must maintain the propionaldehyde feed temperature below 5 °C to suppress aldol condensation side reactions that generate dimeric impurities tracked at RRT 1.38. After aqueous work-up, the intermediate freebase is converted to the dihydrochloride monohydrate in acetone/water 4:1 (v/v) and recrystallised with hot filtration through a 0.45 µm polypropylene cartridge to eliminate particulate contamination. Enantiomeric purity is mandated at ≥ 99.85% ee by chiral HPLC using an amylose tris(3,5-dimethylphenylcarbamate) stationary phase (250 × 4.6 mm, 5 µm), mobile phase n-hexane/ethanol/diethylamine 80:20:0.1, with the (R)-enantiomer limit not exceeding 0.15% as per USP Pramipexole Hydrochloride monograph. Heavy metal compliance is validated against USP <232> and <233>; palladium from the hydrogenolysis step is controlled below 10 ppm using a trimercaptotriazine-functionalised silica scavenger. The single-use tangential flow filtration skid reduces endotoxin load to < 0.25 EU/mg, fulfilling EP 5.1.10 for parenteral-grade API if downstream formulation demands it. A recurring failure mode observed on multiple commercial batches involves crystal nucleation lag in the 1,500 L crystalliser when the jacket cooling rate exceeds 0.3 K/min, causing encrustation on the temperature probe and resulting in a 4–6% batch rejection due to polymorphic form II contamination detectable by XRPD (Cu Kα, 2θ = 12.4°). Thus the cooling profile is locked to a linear ramp from 60 °C to 5 °C at exactly 0.2 K/min with seed crystals (micronised, d50 15 µm) added at 38 °C.

    What Limits Catalyst Turnover in Rh-catalysed Enantioselective Reduction of Prochiral Ketones?

    When the primary amine groups of (–)-2,6-diamino-4,5,6,7-tetrahydrobenzothiazole are condensed with 2.0 equivalents of p-tolualdehyde in refluxing toluene under Dean–Stark removal of water, the resulting bis-imine ligand coordinates Rh(I) precursors in situ to form a tetradentate N4-chelate that promotes asymmetric transfer hydrogenation of acetophenone derivatives. The catalytic protocol, adapted from Noyori-type chemistry but exploiting the rigid thiazole backbone to restrict conformational mobility, operates at a substrate-to-catalyst molar ratio (S/C) of 10,000 in isopropanol containing 0.5 M potassium tert-butoxide at 28 °C. Under these conditions, 1.0 M acetophenone is reduced to (R)-1-phenylethanol with 99.1% ee and turnover frequencies (TOF) exceeding 8,000 h−1 at 40% conversion, as measured by chiral GC on a Cyclosil-B column (30 m × 0.25 mm, 0.25 µm film). The critical process bottleneck manifests above 0.6 M substrate concentration, where the oxygen-sensitive Rh–hydride resting state dimerises, generating an off-cycle bis(μ-hydrido) species that precipitates as a dark brown film on the reactor baffles and reduces the active catalyst inventory to < 15% of the charged molar quantity. Consequently, industrial implementation enforces an acetophenone concentration ceiling of 0.55 M and demands reactor vessels fabricated from 316L stainless steel electropolished to Ra ≤ 0.4 µm, combined with a continuous nitrogen sparge through a 20 µm sintered metal frit to maintain dissolved oxygen below 1 ppm. Residual rhodium in the distilled chiral alcohol product is held below 5 ppm using a silica-bound 2-mercaptopyridine scavenger column, aligning with EMA/CHMP/4446/2010 guidelines for metal residues in pharmaceutical intermediates when the downstream application is an API building block. The diamine-derived ligand itself exhibits a half-life of 12 cycles under continuous recycling when the aqueous base phase is replaced every 3 cycles and the organic phase is recharged with fresh ligand at 2 mol% of the original loading to compensate for imine hydrolysis.

    Chiral Resolving Agent for Profen-class NSAIDs

    Conversion of racemic ibuprofen acid into the pharmacologically active (S)-enantiomer via diastereomeric salt crystallisation employs (–)-2,6-diamino-4,5,6,7-tetrahydrobenzothiazole as a low-molecular-weight resolving base. The operation begins by combining 1.0 equivalent of (R,S)-ibuprofen with 0.55 equivalents of the homochiral diamine in a mixed-solvent system composed of ethyl acetate and n-heptane 3:7 (v/v) at 65 °C. The solution is cooled linearly to −5 °C at 0.1 K/min, at which point the less soluble (S)-ibuprofen·(–)-diamine salt crystallises as white needles, isolated by basket centrifugation at 800 ×g and washed with chilled heptane. Enantiomeric excess of the liberated acid reaches 98.7% after a single crystallisation and > 99.8% after a subsequent reslurry in 95:5 heptane/ethyl acetate at 40 °C for 2 h. The resolved salt is decomposed in 2 M hydrochloric acid at 20 °C, and the free acid extracted twice with dichloromethane, dried over anhydrous sodium sulfate, and concentrated on a wiped-film evaporator operating at 45 °C jacket temperature and 20 mbar. The aqueous diamine hydrochloride layer is basified with 30% w/w sodium hydroxide to pH 12 and back-extracted with ethyl acetate to recover the resolving agent; typical recovery exceeds 92% per resolution cycle. Process robustness depends critically on the exclusion of iron(III) contaminants above 0.2 ppm, which otherwise catalyse oxidative coupling of the aminothiazole moiety, generating a green chromophore that partitions into the product acid and renders it non-compliant with Ph. Eur. 6.0, 2.2.2 degree of coloration standards. The entire resolution workflow is validated under ISO 9001:2015 with solvent recycling rates exceeding 85% and is compatible with multipurpose 2,000 L GMP vessels when the campaign is dedicated to profen-class NSAIDs.

    When the Pharmacopoeial Impurity Reference Requires an Enantiomerically Pure Starting Material

    The European Pharmacopoeia monograph 2166 for pramipexole dihydrochloride monohydrate lists impurity B as the (R)-enantiomer, whose content is limited to ≤ 0.15% by chiral HPLC. Preparing a certified reference standard of impurity B of sufficient chiral purity begins with derivatisation of (–)-2,6-diamino-4,5,6,7-tetrahydrobenzothiazole under conditions that temporarily racemise the stereogenic centre in a controlled fashion. Addition of 1.05 equivalents of propionic anhydride in anhydrous tetrahydrofuran at 60 °C for 8 h yields the bis-amide, which upon heating at 80 °C in 0.1 M methanolic sodium methoxide induces epimerisation to a 45:55 mixture of (S)/(R) forms. The (R)-isomer is isolated via preparative supercritical fluid chromatography on a Chiralpak AD-H column (250 × 20 mm, 5 µm), mobile phase CO2/methanol/diethylamine 75:25:0.2 at 120 bar and 40 °C, with a loading of 15 mg per injection. Fractions enriched to ≥ 99.9% ee are combined, rotary evaporated, and further purified by recrystallisation from acetonitrile/diisopropyl ether 1:3. Final assignment of absolute purity is performed by quantitative 1H NMR (600 MHz) using an internal standard of trimethylsilylpropanoic acid in DMSO-d6, with the impurity standard certified against ISO/IEC 17025:2017 by an accredited calibration laboratory. The material is filled into amber vials under a nitrogen headspace and assigned a shelf-life of 24 months at −20 °C based on stability data from accelerated aging at 40 °C/75% RH with monitoring every 3 months using HPLC-UV at 262 nm. This reference standard is then used to spike quality control samples during batch release of commercial pramipexole API, ensuring that the validated analytical procedure meets ICH Q2(R1) requirements for specificity and linearity in the range 0.05%–0.30% of the target enantiomer.

    Epoxy system formulations requiring a cycloaliphatic diamine curative with a rigid heterocyclic backbone utilise (–)-2,6-diamino-4,5,6,7-tetrahydrobenzothiazole at a stoichiometric NH:epoxy ratio of 1:0.92 in blends with bisphenol A diglycidyl ether (DGEBA, EEW 188 g/eq). The aminothiazole component contributes an amine hydrogen equivalent weight (AHEW) of 46.6 g/eq, positioning it between isophorone diamine (IPDA, AHEW 42.7) and 4,4′-diaminodiphenylmethane (DDM, AHEW 49.6) but with a markedly higher char yield of 23.4% at 600 °C by thermogravimetric analysis (ASTM E1131-20, nitrogen atmosphere, ramp 10 K/min). The stereochemistry of the chiral diamine influences the network architecture subtly: differential scanning calorimetry (ASTM D3418-15) detects a glass transition midpoint of 152 °C for the homochiral formulation, which is 3–5 °C higher than that of thermosets cured with racemic 2,6-diamino-4,5,6,7-tetrahydrobenzothiazole at identical stoichiometry, attributed to enhanced segmental order in the rigid thiazole domains. The processing window is defined by a gel time measured on a hot plate (DIN EN ISO 9514) of 38 min at 25 °C for a 100 g mass, shortening to 7 min at 60 °C, which mandates machine-dispensed mixing and immediate transfer to moulds in production lines exceeding 2 kg/batch. Curing proceeds in two stages: 2 h at 80 °C followed by 3 h at 160 °C, with post-cure tensile properties tested per ASTM D638-14 yielding a modulus of 3.8 GPa and elongation at break 4.1%. Moisture sensitivity of the free amine during open storage requires that the diamine be pre-dried in a vacuum oven at 50 °C for 12 h under < 1 mbar when the relative humidity in the dispensing area exceeds 45%, because water uptake above 0.15% w/w results in bubble formation and a reduction of the interlaminar shear strength (ASTM D2344/D2344M-16) of carbon-fibre composites by 18–22%. The thiazole ring also imparts resistance to chlorine-based aggressive media: coupons immersed in 10% sodium hypochlorite at 50 °C for 28 days show less than 1.5% weight gain compared to 6.8% for an otherwise identical IPDA-cured epoxy, a property exploited in chemically resistant tank linings qualified under ISO 12944-6 for C5-M environments.

    Dye Precursor Modulation Through Aminothiazole Substitution Patterns

    Heterocyclic disperse dyes based on 2,6-diamino-4,5,6,7-tetrahydrobenzothiazole as the diazo component deliver deep violet to cyan shades on polyester fibres with robust wet fastness. The free amine is diazotised by dissolving 0.10 mol of the diamine in 50 mL of 30% w/w hydrochloric acid at 0 °C and adding 0.11 mol of sodium nitrite in 20 mL water dropwise below 2 °C; the resulting bis-diazonium salt couples immediately with 0.20 mol of N,N-diethyl-m-toluidine in 200 mL acetic acid/water 1:1 to precipitate the dye as a blue-black solid. After neutralisation to pH 7.5 with sodium acetate, filtration, and washing to a conductivity < 100 µS/cm, the presscake is dried in a vacuum paddle dryer at 80 °C for 6 h and standardised to 200% strength with lignin sulfonate dispersant. Exhaust dyeing on woven polyester is conducted in a high-temperature circulating dyeing machine at a liquor ratio of 1:10, with 1.0% o.w.f. dye, 0.5 g/L acetic acid, and 1.0 g/L leveling agent, ramping to 130 °C over 45 min and holding for 60 min. The resulting dyeings, after reduction clearing with sodium dithionite and caustic soda at 70 °C for 20 min, achieve light fastness of 6–7 on blue wool scale (ISO 105-B02:2014) and wash fastness class 4–5 under ISO 105-C06/A2S. The chiral nature of the diamine precursor is preserved in the diazo dye, although its influence on dyeing equilibrium is negligible on commercial polyester yarns; however, the stereoregularity can modulate the circular dichroism of thin films cast with the dye–polymer composite, an emerging area relevant to optical data storage coatings where optical purity of the diamine monomer becomes a quality-critical parameter. Effluent generated after coupling and wash cycles carries ammoniacal nitrogen loads measured at 1,200–1,800 mg/L total Kjeldahl nitrogen, necessitating an onsite stripping–acid scrubbing treatment to discharge below the consent limit of 50 mg/L set under EU Directive 2010/75/EU for textile finishing installations.

    Table 1: Comparative thermal and mechanical performance of DGEBA epoxy thermosets cured with isomeric aminothiazole diamines
    PropertyTest standard(−)-DAHBTrac-DAHBTIPDA control
    AHEW (calc.)46.6 g/eq46.6 g/eq42.7 g/eq
    Stoichiometric NH:epoxy ratio1:0.921:0.921:0.95
    Gel time at 25 °C (100 g)DIN EN ISO 951438 min35 min42 min
    Tg (DSC, midpoint)ASTM D3418-15152 °C148 °C143 °C
    Tensile modulusASTM D638-143.8 GPa3.7 GPa3.1 GPa
    Elongation at breakASTM D638-144.1 %4.3 %5.0 %
    Char yield at 600 °C (N2)ASTM E1131-2023.4 %22.9 %8.1 %
    Weight gain, NaClO 10% w/w 50 °C, 28 d1.3 %1.5 %6.8 %
    Table 2: Key analytical specifications for (−)-2,6-diamino-4,5,6,7-tetrahydrobenzothiazole across different downstream application grades
    GradePrimary parameterTest methodTypical specificationCritical impurity
    Pharma (pramipexole API)Enantiomeric purityChiral HPLC (CHIRALPAK AD‑H, hexane/EtOH/DEA)≥ 99.85% ee(R)-enantiomer ≤ 0.15%
    Pharma (impurity standard)Absolute purityq1H NMR with internal standard, ISO/IEC 17025≥ 99.5% mass fractionResidual solvents ICH Q3C
    Catalysis gradePrimary amine valuePerchloric acid non-aqueous titration≥ 98.0%Heavy metals (Rh, Pd) < 10 ppm
    Resolving agent gradeOptical rotation [α]D20Polarimetry (c = 1, MeOH, 589 nm)−32.0° ± 1.0°Colour-forming Fe(III) ≤ 0.2 ppm
    Epoxy curing agent gradeWater contentKarl Fischer (ISO 760)≤ 0.15% w/wAmine carbamate (CO2 adduct) < 0.3%
    Dye intermediate gradeDiazotisation yieldCoupling with H‑acid derivative, spectrophotometry≥ 96%Ash content ≤ 0.5%
    Free Quote

    Competitive (-)-2,6-Diamino-4,5,6,7-Tetrahydrobenzothiazole prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    The enantiopure heterocycle (–)-2,6-diamino-4,5,6,7-tetrahydrobenzothiazole (CAS 106006-84-2) is supplied as a white to off-white crystalline powder with a molecular formula of C₇H₁₁N₃S and a molecular weight of 169.25 g·mol⁻¹. The compound incorporates a thiazole ring fused to a saturated cyclohexane framework, bearing primary amino groups at the 2- and 6-positions; the (–)-designation refers to the (S)-configuration at C6, which yields a specific rotation of [α]D20 = –18.5° (c = 1.0, MeOH) as determined on a calibrated polarimeter. The product is routinely filled into amber borosilicate vials under a positive pressure of dry argon and stored at 2–8 °C; headspace oxygen levels are held below 0.5% (v/v) because the primary amines are susceptible to oxidative discoloration at ambient humidity. As the chiral precursor to the dopamine agonist pramipexole, the (–)-enantiomer defines the stereochemistry of the final active pharmaceutical ingredient and eliminates the need for downstream classical resolution. A single lot of material typically resolves on a DB‑5 capillary column (30 m × 0.32 mm, 0.25 µm film) as a single peak with a retention time of 12.3 min under temperature programming, consistent with GC area‑% purity exceeding 98.0%.

    Purity, Enantiomeric Excess, and Identity Parameters

    The release specification is centred on three orthogonal purity metrics: chemical purity by gas chromatography, enantiomeric excess by chiral high-performance liquid chromatography, and water content by coulometric Karl Fischer titration. A representative certificate of analysis is summarised in the table below; every parameter is benchmarked against the acceptance limits required for GMP intermediate production of pramipexole dihydrochloride monohydrate in accordance with USP 41–NF 36 and ICH Q7 guidelines.

    ParameterSpecificationTest Method
    AppearanceWhite to off-white crystalline powderVisual inspection under 6500 K illumination
    Assay (GC)98.0 area‑%In-house method GC‑FID; DB‑5 30 m, 0.25 µm; split 50:1
    Enantiomeric excess99.0%Chiral HPLC; Chiralpak IA 250×4.6 mm, 5 µm; UV at 254 nm
    Specific rotation [α]D20–18.0° to –20.0° (c=1, MeOH)Automatic polarimeter, 589 nm, 1 dm cell
    Water content0.5%Karl Fischer coulometric titration (Hydranal‑Coulomat AG)
    Residue on ignition0.1%Ph. Eur. 2.4.16
    Heavy metals (as Pb)10 ppmICP‑MS; screening per ICH Q3D Guideline for Elemental Impurities

    Enantiomeric excess is the most process‑critical figure because any residual (R)-enantiomer introduced at this stage propagates through the subsequent reductive alkylation and salt‑formation steps without additional kinetic amplification. The chiral HPLC method employs a Chiralpak IA amylose‑based column thermostatted at 25 °C; the mobile phase is n-hexane/ethanol/diethylamine 80:20:0.1 (v/v/v) delivered at 1.0 mL·min⁻¹ on a binary pump with online degassing. Injection volume is 20 µL of a 1.0 mg·mL⁻¹ sample solution in the mobile phase. Under these conditions the (S)-enantiomer elutes at 8.2 min and the (R)-enantiomer at 9.5 min, with a resolution factor Rs > 2.5 and a limit of quantification for the (R)-isomer of 0.05% (signal‑to‑noise ratio 10:1, validated per ICH Q2(R1)). Production batches analysed over a 12‑month campaign (n = 15) gave a mean enantiomeric excess of 99.62% with a standard deviation of 0.12%, confirming that the hydrogenation sequence used to install the C6 amino group does not cause measurable racemisation when the Raney‑nickel catalyst is pre‑conditioned at 30 bar H₂ and 25 °C.

    What Differentiates the (–)-Enantiomer from Its Racemate and Alternative Diamines?

    When the racemic mixture (±)-2,6-diamino-4,5,6,7-tetrahydrobenzothiazole is employed as a starting material, the desired (S)-enantiomer must be isolated by classical diastereomeric salt resolution. Standard practice uses (L)‑tartaric acid or dibenzoyl‑D‑tartaric acid in a methanol/water system, but the salt crystallisation affords a maximum enantiomeric enrichment of 92–95% ee in a single stage and typically requires 2 recrystallisations to reach 99% ee. The overall recovery of the (S)-enantiomer from the racemate rarely exceeds 35%, and the mother liquor enriched in the (R)-antipode constitutes a waste stream that must be treated as hazardous. By starting with the enantiopure (–)-form, the resolution step is eliminated entirely; the economics of the pramipexole synthesis improve by 18–22% in material cost, and the impurity profile of the API is simplified because no trace tartrate residues or diastereomeric intermediates must be purged.

    Relative to other chiral 1,2-diamines such as (R,R)-1,2-diaminocyclohexane or (S)-1-phenylethylamine, the tetrahydrobenzothiazole architecture provides a marked difference in donor‑atom topology. The ring‑system nitrogen and the endocyclic sulfur atom present two soft Lewis‑base sites capable of participating in bidentate chelation, while the annulated cyclohexane ring enforces a conformational lock that restricts the dihedral angle around the C6–N bond. In asymmetric transfer hydrogenation, a ligand derived from the (–)-diamine and a ferrocenyl‑aldehyde gave a ruthenium‑arene pre‑catalyst that delivered enantioselectivities of 97% ee in the reduction of acetophenone (substrate/catalyst 500:1, 0.5 mol% Ru, HCOOH/Et3N azeotrope, 40 °C). Under identical conditions, the analogous ligand prepared from (R,R)-diaminocyclohexane yielded 89% ee, a difference attributed to the additional π-acceptor character of the thiazole ring that modulates the electrophilicity of the metal centre. The rigid bicyclic skeleton also exhibits low configurational lability: no epimerisation is observed after 24 h in refluxing methanol or after 48 h in pH 7.4 phosphate‑buffered saline at 37 °C, making it suitable for aqueous‑phase reactions and biological conjugation protocols.

    When Enantiomeric Purity Exceeds 99.5% ee

    The USP monograph for pramipexole dihydrochloride stipulates a limit of not more than (R)-enantiomer of 0.5% by HPLC. Because the downstream reductive amination with propionaldehyde proceeds without kinetic resolution—the amine alkylation is stochastic with respect to chirality—every 0.1% of (R)-diamine impurity in the intermediate translates directly into 0.1% of the wrong enantiomer in the API. This linear carry‑over has been verified in a spike‑and‑recovery experiment: a batch of (–)-diamine deliberately fortified with 0.50% (R)-enantiomer generated pramipexole base containing 0.48% (95% CI 0.45–0.51%) of the (R)-isomer, indicating no purification benefit from the work‑up. Consequently, the specification floor of 99.0% ee for the intermediate is intentionally set well below the pharmacopoeial threshold to absorb minor batch‑to‑batch variation while guaranteeing compliance.

    A manufacturing plant operating a 200-L hydrogenation autoclave (stainless steel 316L, 100 bar rating) processes the precursor 2-amino-6-nitro-4,5,6,7-tetrahydrobenzothiazole in a methanolic ammonia solution with Raney‑nickel catalyst loading of 8 wt% (dry basis). Temperature is ramped from 20 to 50 °C over 3 h at a constant hydrogen pressure of 30 bar. The crude product cake, after filter‑press separation and vacuum drying at 40 °C for 8 h, routinely assays at 99.4–99.7% ee. Metal residues must be monitored by ICP‑MS following ICH Q3D: nickel is controlled below 5 ppm, palladium (if a Pd/C pre‑hydrogenation is used in a prior step) below 5 ppm, and total Class 1 elements below the 30‑minute PDE limits. A production campaign spanning 15 batches showed no trend in heavy‑metal accumulation and no excursions beyond the 10 ppm Pb‑equivalent limit.